SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news

 

 

Sports nutrition fuels Glanbia double-digit H1 revenue growth

By Mark Astley+

21-Aug-2014

Glanbia's Global Performance Nutrition business, which includes its Optimum Nutrition brand, was
Glanbia's Global Performance Nutrition business, which includes its Optimum Nutrition brand, was "key contributor" to the group's H1 growth.

Fueled by the continuing success of its Global Performance Nutrition division, Irish dairy Glanbia recorded a double-digit increase in revenue for the first half of 2014.

In its results for the six months ended July 5 2014, published yesterday, Glanbia reported sales of €1.79bn (US$2.37bn) - a 10.7% increase on a constant currency basis on the €1.66bn (US$2.2bn) achieved in H1 2013

Earnings before interest, taxes, depreciation, and amortization (EBITDA) also jumped 10.3% - from €122.2m (US$162m) in the same period last year to €129.5m (U$172m). 

Kilkenny-based Glanbia branded its Global Performance Nutrition business, which incorporates its Optimum Nutrition, BSN, and ABB brands, the "key contributor" to these increases.

The sport nutrition business, which boasts the US as its single largest market, reported sales of €374.6m (US$496.9m) in H1 2014 - up 21.8% on €320.2m (US$425m) in the first half of last year. 

Glanbia's attributed this in part to the January 2014 acquisition of Scandinavian sports nutrition company, Nutramino.

Revenue from its Global Ingredients division, comprised of its US cheese and ingredients operations, jumped 10.7% to €565.8m (US$751m) - a "satisfactory performance" in Glanbia's eyes given the milk procurement issues in Idaho it experienced and an "unfavorable whey pricing dynamic."

Sales from its consumer business Dairy Ireland - down 7.7% to €383.2m (US$508m) - and its Joint Ventures and Associates segments - up 19.3% to €503.4m (US$668m) - were meanwhile "in line with expectations."

On the back of its first half performance, Glanbia has reiterated its earning guidance for 2014 of 8% to 10% growth.

"Overall, the outlook for the group for 2014 is positive," said Glanbia's half-year results.

"While Global Performance Nutrition is expected to be the main driver of growth, Dairy Ireland is expected to deliver an improved performance versus the prior year with the Global Ingredients Ireland largely unchanged."

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars